Sarah Christine Lidstone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sarah Christine Lidstone has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Arman Rahmim
Membr, IEEE, University of British Columbia, Vancouver, BC V6T 1Z1; Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205
1 shared publication Doris J. Doudet
Member IEEE, University of British Columbia (UBC). Vancouver. B.C. V6T 1Z1. Canada
1 shared publication- Ju-Chieh Cheng
Department of Physics and Astronomy, University of British Columbia, Vancouver BC V6T 1Z1
1 shared publication - Katherine Dinelle
Department of Physics and Astronomy, University of British Columbia, Vancouver BC V6T 1Z1
1 shared publication - Siobhan McCormick
University of British Columbia, Vancouver, Canada
1 shared publication - Stephan Blinder
Pacific Parkinson's Research Centre, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada
1 shared publication
Latest Publications
- 13 September 2014
- Published by Springer Nature
- Vol. 225, 139-147
Great Expectations: The Placebo Effect in Parkinson’s Disease
Our understanding of the neural mechanisms underlying the placebo effect has increased exponentially in parallel with the advances in brain imaging. This is of particular importance in the field of Parkinson’s disease, where clinicians have described placebo effects in their patients for decades. Significant placebo effects have been observed in clinical trials for medications as well as more invasive surgical trials including deep-brain stimulation and stem-cell implantation. In addition to placebo effects occurring as a byproduct of randomized controlled trials, investigation of the placebo effect itself in the laboratory setting has further shown the capacity for strong placebo effects within this patient population. Neuroimaging studies have demonstrated that placebos stimulate the release of dopamine in the striatum of patients with Parkinson’s disease and can alter the activity of dopamine neurons using single-cell recording. When taken together with the findings from other medical conditions discussed elsewhere in this publication, a unified mechanism for the placebo effect in Parkinson’s disease is emerging that blends expectation-induced neurochemical changes and disease-specific nigrostriatal dopamine release.
- 13 September 2014
- Published by Springer Nature
- Vol. 225, 139-147
Great Expectations: The Placebo Effect in Parkinson’s Disease
Our understanding of the neural mechanisms underlying the placebo effect has increased exponentially in parallel with the advances in brain imaging. This is of particular importance in the field of Parkinson’s disease, where clinicians have described placebo effects in their patients for decades. Significant placebo effects have been observed in clinical trials for medications as well as more invasive surgical trials including deep-brain stimulation and stem-cell implantation. In addition to placebo effects occurring as a byproduct of randomized controlled trials, investigation of the placebo effect itself in the laboratory setting has further shown the capacity for strong placebo effects within this patient population. Neuroimaging studies have demonstrated that placebos stimulate the release of dopamine in the striatum of patients with Parkinson’s disease and can alter the activity of dopamine neurons using single-cell recording. When taken together with the findings from other medical conditions discussed elsewhere in this publication, a unified mechanism for the placebo effect in Parkinson’s disease is emerging that blends expectation-induced neurochemical changes and disease-specific nigrostriatal dopamine release.
- 1 January 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 5 (10823654) , 2653-2657
Comparison between the ROI based and pixel based analysis for neuroreceptor studies performed on the high resolution research tomograph (HRRT)
Parametric imaging refers to evaluating kinetic model parameters from time activity curves (TACs) estimated from every image pixel in contrast to region of interest (ROI) based analysis where the parameters are evaluated from TACs derived from predefined ROIs. Parametric imaging is thus more sensitive to statistical and motion induced noise. Here we evaluate the feasibility of parametric imaging for two modeling approaches, the simplified reference tissue model (RTM) and the tissue input Logan graphical method (L), for data acquired on the high resolution research tomograph (HRRT). The small image pixel size of this tomograph makes the image pixel values particularly sensitive to statistical noise and to artifacts due to subject motion. Comparing parametric BP estimates to those obtained with the ROI based approach a large downward bias (up to 28%) was observed for the Logan approach, while no bias was observed for the RTM method. The correlation between the BP values obtained with the ROI and parametric approach was better and less affected by motion for RTM (r 2 > 0.9) compared to L (r 2 > 0.45). The correlation between the BP obtained with the two methods was found to be significantly affected by patient motion and in general better for the ROI based approach. We conclude that parametric imaging on the HRRT is feasible for selected modeling approaches.
- 1 January 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 5 (10823654) , 2653-2657
Comparison between the ROI based and pixel based analysis for neuroreceptor studies performed on the high resolution research tomograph (HRRT)
Parametric imaging refers to evaluating kinetic model parameters from time activity curves (TACs) estimated from every image pixel in contrast to region of interest (ROI) based analysis where the parameters are evaluated from TACs derived from predefined ROIs. Parametric imaging is thus more sensitive to statistical and motion induced noise. Here we evaluate the feasibility of parametric imaging for two modeling approaches, the simplified reference tissue model (RTM) and the tissue input Logan graphical method (L), for data acquired on the high resolution research tomograph (HRRT). The small image pixel size of this tomograph makes the image pixel values particularly sensitive to statistical noise and to artifacts due to subject motion. Comparing parametric BP estimates to those obtained with the ROI based approach a large downward bias (up to 28%) was observed for the Logan approach, while no bias was observed for the RTM method. The correlation between the BP values obtained with the ROI and parametric approach was better and less affected by motion for RTM (r 2 > 0.9) compared to L (r 2 > 0.45). The correlation between the BP obtained with the two methods was found to be significantly affected by patient motion and in general better for the ROI based approach. We conclude that parametric imaging on the HRRT is feasible for selected modeling approaches.